U.K. Greenlights World's First Crispr Gene Editing Therapy
The treatment, authorized for sickle cell disease and beta thalassemia, is being considered for approval by the FDA, with a decision expected in December.
Source: forbes.com
Page 26 - Crispr News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Crispr Today - Breaking & Trending Today
CRISPR treatment has been greenlit in UK in global first. Here's who it could help | News
The United Kingdom has become the first country to give regulatory approval to a medical treatment involving the revolutionary CRISPR gene editing tool.
Source: wfft.com
The First Crispr Medicine Just Got Approved
The gene-editing therapy, called Casgevy, uses Crispr to prevent debilitating pain in patients with sickle cell disease. It also eliminates the need for regular blood transfusions in people with beta thalassemia.
Source: wired.com
Casgevy: Sickle cell CRISPR 'cure' is the start of a revolution in medicine
The approval of a first CRISPR treatment, for sickle cell disease and beta thalassemia, is just the start for a technology still in its infancy
Source: newscientist.com
Historic MHRA exa-cel win bagged, Crispr/Vertex await FDA nod
With a landmark U.K. approval in hand for Casgevy (exagamglogene autotemcel [exa-cel]) to treat sickle cell disease and transfusion-dependent beta thalassemia, Crispr Therapeutics AG and partner Vertex Therapeutics Inc. are turning their attention to the PDUFA dates set by the U.S. FDA for the treatment in both conditions.
Source: bioworld.com